Skip to content
Parakho

Arvaya Healthcare Ltd

BSE 524723

Q1 FY27, unaudited

Revenue
₹29.91 Cr
Profit after tax
₹0.53 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations29.91—9.11
Other income0.19—1.40
Total income30.10—10.51
Employee benefit expense5.47—1.90
Finance costs1.39—0.41
Depreciation & amortisation2.20—0.62
Total expenses29.54—9.42
Profit before tax0.56—1.09
Tax expense0.03—0.19
Profit after tax0.53—0.90
Total comprehensive income0.55—0.91
Earnings per share
Earnings per share, basic₹0.08₹0.69
Earnings per share, diluted₹0.08₹0.69

Q1 FY27 — unaudited, from the company’s filing with BSE. Source

FY26 — from the company’s filing with BSE. Source

Q1 FY27 results for every company Parakho holds

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Arvaya Healthcare Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 57 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Services › Trading & Distributors

Classification as published by BSE.

Companies also in Trading & Distributors, in alphabetical order

All 205 companies in Trading & Distributors

Page generated from filings held to 12 Oct 2026.